Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, GlaxoSmithKline Pharmaceutical has informed that Pradeep V. Bhide (Din: 03304262) has voluntarily relinquished his position as Board member with effect from closing hours of 7th January 2025. He has confirmed that there are no other material reasons other than provided in the resignation letter. Further Pradeep V. Bhide is on the Board of the company and is a committee member of the Audit & Risk Management Committee. The company has enclosed a copy of the resignation letter along with detailed reasons for resignation as submitted by Pradeep V. Bhide to the Board of the Company. The Company places on record its appreciation for the guidance and support provided by Pradeep V. Bhide during his long tenure.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: